Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Macrogenics (MGNX) Return on Sales (2016 - 2025)

Macrogenics (MGNX) has disclosed Return on Sales for 14 consecutive years, with 0.34% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Sales rose 2.0% to 0.34% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.52%, a 83.0% increase, with the full-year FY2025 number at 0.5%, down 5.0% from a year prior.
  • Return on Sales was 0.34% for Q4 2025 at Macrogenics, down from 0.23% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.23% in Q3 2025 to a low of 16.87% in Q2 2024.
  • A 5-year average of 3.29% and a median of 3.14% in 2021 define the central range for Return on Sales.
  • Peak YoY movement for Return on Sales: crashed -1339bps in 2024, then skyrocketed 1517bps in 2025.
  • Macrogenics' Return on Sales stood at 4.12% in 2021, then soared by 104bps to 0.16% in 2022, then plummeted by -2908bps to 4.6% in 2023, then surged by 92bps to 0.36% in 2024, then rose by 5bps to 0.34% in 2025.
  • Per Business Quant, the three most recent readings for MGNX's Return on Sales are 0.34% (Q4 2025), 0.23% (Q3 2025), and 1.69% (Q2 2025).